Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jan 17.
Published in final edited form as: Neurologist. 2008 May;14(3):181–191. doi: 10.1097/NRL.0b013e31816606b9

Malformations of cortical development

Trudy Pang 1, Ramin Atefy 2, Volney Sheen 3
PMCID: PMC3547618  NIHMSID: NIHMS378221  PMID: 18469675

Abstract

Background

Malformations of cortical development (MCD) are increasingly recognized as an important cause of epilepsy and developmental delay. MCD encompass a wide spectrum of disorders with various underlying genetic etiologies and clinical manifestations. High resolution imaging has dramatically improved our recognition of MCD.

Review Summary

This review will provide a brief overview of the stages of normal cortical development, including neuronal proliferation, neuroblast migration, and neuronal organization. Disruptions at various stages lead to characteristic MCD. Disorders of neurogenesis give rise to microcephaly (small brain) or macrocephaly (large brain). Disorders of early neuroblast migration give rise to periventricular heterotopia (neurons located along the ventricles), whereas abnormalities later in migration lead to lissencephaly (smooth brain) or subcortical band heterotopia (smooth brain with a band of heterotopic neurons under the cortex). Abnormal neuronal migration arrest give rise to over-migration of neurons in cobblestone lissencephaly. Lastly, disorders of neuronal organization cause polymicrogyria (abnormally small gyri and sulci). This review will also discuss the known genetic mutations and potential mechanisms that contribute to these syndromes.

Conclusion

Identification of various gene mutations has not only given us greater insight into some of the pathophysiologic basis of MCD, but also an understanding of the processes involved in normal cortical development.

Keywords: Cortical development, malformations, genes

Introduction

Malformations of cortical development (MCD) are an important cause of epilepsy and developmental delay. It is estimated that up to 40% of children with refractory epilepsy have a cortical malformation1. MCD encompasses a large spectrum of disorders related to abnormal cortical development with varied genetic etiologies, anatomic abnormalities, and clinical manifestations. Whereas many of these disorders were previously diagnosed at autopsy, the use of MRI has dramatically improved our ability to recognize these MCD.

Cerebral cortical development involves a set of highly complex and organized events, including neural stem cell proliferation, migration, and finally neuronal differentiation. Disruptions of these various stages may result in MCD. Disorders due to abnormalities of cell proliferation may cause microcephaly (meaning small brain), megalencephaly (meaning large brain), or cortical dysplasia (meaning focal areas of abnormal neuronal architecture). Disorders of initiation of neuronal migration result in periventricular heterotopia (meaning abnormal nodules of neurons located along the ventricular wall). Disorders of later migration and motility cause disruption of the normal six-layered cortex, such as classical lissencephaly (meaning smooth brain) and subcortical band heterotopia (meaning heterotopic neurons located midway between the surface of the brain and lateral ventricles). Finally, disorders of neuronal arrest can result in neurons that fail to stop upon reaching their intended destination in the cerebral cortex and over-migrate onto the cortical surface as seen in cobblestone lissencephaly. Although cortical development has been separated into these stages, there is significant overlap between the stages and many abnormalities may cause dysfunction at more than one level. Thus, malformation syndromes are typically classified based on the earliest disruption of development. These concepts serve as the basis for the latest classification scheme for these disorders2.

The pathogenesis of these malformations is multifactorial: genetic mutations or environmental insults, whether acquired in utero at different stages of brain development, or during the perinatal or postnatal period after corticogenesis may all contribute to the development of these syndromes3,4. The timing, severity, and type of environmental influences, as well as genetic factors, will ultimately determine the type and extent of malformation syndrome.

Work in elucidating the genetic basis of various MCD has given us greater insight and understanding into the underlying pathophysiologic basis of these disorders, and will form the focus of this review. Different mutations of the same gene can cause different phenotypes, based on the degree of protein dysfunction (so termed genotype-phenotype correlation). Loss or disruption of the functional domains within a gene ultimately determines the phenotype of the disorder. Alternatively, specific mutations in a given gene can also lead to a gain of function for the aberrant protein. Mosaicism can occur when the mutation is present in a subpopulation of cells, whereas germ line mutations typically lead to expression of the mutant gene in all cells. Functional mosaicism occurs due to X-inactivation in which the mutation is present on one X chromosome but not the other. The mutant gene is thus expressed only in cells in which the mutant gene is found on the active X chromosome. This process explains why affected females are often less severely affected than males who have the same mutation. An understanding of some of the underlying genetic basis for these disorders will play an important role in genetic counseling of affected individuals and their families.

Normal cortical development

Human cortical development encompasses a series of complex and overlapping processes, including neuronal precursor proliferation at the ventricular zone, neuroblast departure from the ventricular zone, neuroblast migration, migration arrest, and neuronal organization.

Neuronal progenitor cells originate from the periventricular and subventricular zones and undergo different patterns of development and migration paths, before they eventually populate the cerebral cortex. Neural precursor cells may undergo cell division in symmetric and asymmetric patterns. Symmetric cell division yields two identical daughter cells that continue to divide in a similar fashion and serve to replenish the population of progenitor cells. Asymmetric cell division leads to two different types of cells: 1. progenitor cells that re-enter the cell cycle, 2. immature neuronal cells (neuroblasts) that will migrate into the overlying cortical plate5.

Migration of neuroblasts begins with appropriate orientation of the cells prior to departure from the ventricular zone and these neuroblasts must have the ability to adhere to the scaffolding created by the radial glia that guide them during migration. To ensure correct orientation, the neuroblasts actually move in a retrograde fashion and make contact with the ventricular surface before migrating out to the cortical plate6. Excitatory or glutamatergic cortical neurons have a leading process that adheres to the radial glial fibers as they migrate radially from the ventricular zone to the cerebral cortex. Inhibitory or GABAergic cortical interneurons originate from the germinal zone of the basal ganglia and the ventricular zone. Rather than migrating radially, immature neurons from the lateral, medial, and caudal ganglionic eminences migrate tangentially first, and then radially to the various layers of the cerebral cortex6,7,8,9.

Migrating neurons must stop in their appropriate laminar position once they reach the cortical plate. The cerebral cortex develops in an “inside-out” fashion. In other words, the earlier generated neurons form the deeper layers (V/VI) while later-generated neurons migrate past the earlier formed neurons to form the superficial layers (II/III). Both structural barriers at the pial surface of the brain and molecular stop signals are involved in mediating neuronal migration arrest10. Finally, cortical connections formed during gestation and infancy are modified through pruning of synapses and cellular apoptosis.

Disorders due to abnormal neurogenesis

The balance between cell proliferation and cell death determines the ultimate number of neurons or glia in the developed brain. Diffuse perturbations in this delicate balance (or perturbations occurring very early in development such that subsequent cell progeny are affected) results in microcephaly or macrocephaly. Focal disruptions (typically due to mosaicism) can lead to focal cortical dysplasia.

Microcephaly

Microcephaly, or small brain, refers to a head circumference that is more than two standard deviations below the population mean after correction for age and sex. It may result from abnormal cell division or proliferation. A number of processes can cause microcephaly and are often accompanied by involvement of other organ systems. Primary microcephaly, known as microcephaly vera, refers to a small brain which results from processes affecting cortical development alone without involvement of other organs. On pathologic examination, occasionally, a simplified gyral pattern (oligogyria) and disruption of the gray matter along the ventricular zone may be seen, along with hypomyelination and cerebellar hypoplasia. Clinically, these patients have mental retardation and some may also have epilepsy. Radiographic findings are determined by the underlying cause of microcephaly. In primary microcephaly, a grossly normal brain (Figures 1A and 1B) is frequently seen on brain MRI11.

Figure 1.

Figure 1

A. Normal brain. Axial T1-weighted MRI. Camera lucida rendering of the normal brain is to the right. B. Microcephaly. Axial T1-weighted MRI in a patient with a ASPM mutation. Camera lucida rendering to the right shows the region of disruption (grey) along the ventricular zone giving rise to microcephaly. C. Periventricular heterotopia. Axial T2-weighted brain MRI of a patient with a FLNA mutation. Note the nodules of heterotopic gray matter lining the lateral ventricles bilaterally. Camera lucida rendering to the right shows regions of disruption (grey) involving gray matter nodules along the lining of the ventricle. D. Subcortical band heterotopia. Axial T1-weighted brain MRI of a patient with a DCX mutation. Note the thick band of gray matter running deep and parallel to the thinned outer cortex. A thin band of white matter separates the outer cortex and the inner subcortical band of heterotopic neurons. Camera lucida rendering to the right shows the region of disruption (grey) involving a band of neurons midway between the cortical surface and ventricles. E. Classical lissencephaly (Type I lissencephaly). Axial T1-weighted brain MRI of type I or classic lissencephaly in a patient harboring a LIS1 mutation. The brain has an “hour-glass” appearance with agyria and pachygyria. Note the greater severity of lissencephaly in the parietal and occipital lobes. Camera lucida rendering to the right shows a region of disruption (grey) demonstrating a disruption in the lamination of the cortex. F. Cobblestone lissencephaly (Type II lissencephaly). Axial T2-weighted brain MRI of type II or cobblestone lissencephaly. Note the cobblestone appearance of the thinned cortex, absent corpus callosum, and severely enlarged ventricles. Camera lucida rendering to the right shows regions of disruption (grey) demonstrating nodules of neurons on the surface of the cortex.

Four autosomal recessive genes are associated with microcephaly (Table 1), namely, Microcephalin, ASPM (abnormal spindle-like, microcephaly-associated), CDK5RAP2 (CDK5 regulatory subunit associated protein 2) and CENPJ (centromere protein J). These genes seem to play a role in cell division during neurogenesis at the ventricular neuroepithelium. The Microcephalin gene is thought to also play a role in DNA repair. Abnormal DNA repair due to loss of the Microcephalin gene causes increased neural progenitor cell death along the ventricles. Additional studies suggest that the Microcephalin protein is a centrosomal protein12 and plays a role in the control of cell-cycle timing13. ASPM is a gene that encodes for a very large centrosomal protein14 that is essential for normal neuroblast mitotic spindle function in Drosophila15. CDK5RAP2 and CENPJ encode for centrosomal proteins that are found at the spindle poles of mitotic cells, along the ventricular neuroepithelium. Thus, all of the known genes for microcephaly vera play an important role in neurogenesis by regulation of microtubules and cell cycle progression during cell division16,17.

Table 1.

Malformations of cortical development with associated genes and clinical features

Developmental stage Cortical malformation Genetic cause Clinical features
Abnormal neurogenesis
Microcephaly ASPM Mental retardation, not generally associated with epilepsy, autosomal recessive inheritance
Microcephalin
CDK5RAP2
CENPJ
Hemimegalencephaly Unknown Mental retardation, early onset seizures (frequently intractable epilepsy), +/- neurocutaneous syndrome
Focal cortical dysplasia Unknown Most common, focal and generalized Seizures
Abnormal neuronal migration
Periventricular heterotopia FLNA Normal intelligence, adolescent onset seizures, X-linked disorder with male lethality
ARFGEF2 Mental retardation, microcephaly, autosomal recessive inheritance, rare
Subcortical band heterotopia DCX Subcortical band heterotopia in females, mental retardation, epilepsy, X-linked disorder
Lissencephaly LIS1 Miller-Dieker syndrome (characteristic facial features), autosomal dominant inheritance
DCX Lissencephaly in males, X-linked
TUBA1A Lissencephaly, clinical features similar those caused by LIS1 and DCX, de novo mutations
ARX Associated with ambiguous genitalia, hypothalamic dysfunction, neonatal epilepsy, X-linked disorder
RELN Associated with cerebellar hypoplasia, epilepsy, autosomal recessive inheritance
Abnormal arrest in neuronal migration
Cobblestone lissencephaly Fukutin Fukuyama congenital muscular dystrophy
POMGnT1 Muscle-eye-brain disease
POMT1 Walker-Warburg Syndrome
Abnormal neuronal organization
Polymicrogyria GPR56 Bilateral frontoparietal polymicrogyria, Epilepsy
Schizencephaly EMX2 Type 2 (open cleft)

Disruption of genes involved in microtubule and centrosome function in mice results in similar impairments in neural progenitor proliferation and cause microcephaly18. For example, Nde1 is a microtubule-associated protein required for centrosome duplication, and the formation and function of the mitotic spindle. Nde1 expression is also associated with the centrosome, kinetochore, and spindle. Phosphorylation of the protein during mitosis causes it to associate with mitotic spindles and participate in dynein-mediated transport of kinetochore proteins to spindle poles along microtubules during proliferation. Loss of mouse Nde1 function in cortical progenitors causes defects in mitotic progression, mitotic orientation, and mitotic chromosome localization in cortical progenitors. This disruption in centrosome duplication and mitotic spindle assembly produces a small brain in Nde1 deficient mice.

Hemimegalencephaly

Hemimegalencephaly is characterized by overgrowth of one hemisphere, a part of a hemisphere, or one hemisphere with partial involvement of the other hemisphere. The pathology typically reveals cortical dysplasia, white matter abnormalities, abnormal cell types, and polymicrogyria. Hemimegalencephaly may be an isolated finding or it may exist as a feature of a number of syndromes, including neurocutaneous syndromes such as Klippel-Trenauney syndrome and hypomelanosis of Ito19. Not surprisingly, given the significant brain malformation, patients typically have mental retardation and almost always have epilepsy which can become intractable. Seizures may begin within the first 6 months of life, often with partial onset arising from the enlarged area of the brain with or without secondary generalization. Infantile spasms and atonic seizures can also occur. Typical MRI findings include enlargement of at least one lobe or one hemisphere, with the occipital region being the most frequently involved11. The underlying white matter may also demonstrate abnormal T1 and T2 signal intensities. The cortex is often thick with pachygyria and heterotopia are commonly seen scattered in various locations. The lateral ventricle is usually enlarged with a straight and pointed frontal horn. The underlying genetic abnormalities are still unclear and additional work is needed to elucidate the heterogeneous genetic bases of this disorder.

Focal cortical dysplasia

Focal cortical dysplasia (FCD) represents a heterogeneous entity resulting from a variety of causes20. Pathological examination demonstrates a range of findings such as dysplastic neurons, balloon cells, and lamination disorganization21,22. FCD can occur throughout the brain, but it is has a predilection for the frontal and temporal lobes22. It is one the most common forms of focal developmental disorder diagnosed in patients with partial epilepsy, constituting approximately 25% of patients23,24. Of these patients, approximately 76% have medically refractory seizures25. For the majority of patients, the onset of epilepsy occurs within the first 11 years of life, with generalized tonic-clonic, tonic, simple partial and complex partial seizures 22 High-resolution MRI plays a key role in the diagnosis of the disorder and typically shows blurring of the junction between gray and white matter, gyral thickening, and abnormal signal such as T2 prolongation in the underlying white matter11. Given the heterogeneity of the disorder, no single genetic abnormality has been identified as a cause.

Disorders due to abnormal neuronal migration

Successful neuronal migration involves several stages: initial departure of neuroblasts from the ventricular zone, motility for migration to the cortical plate, and finally arrest of migration at the appropriate layer. Disruptions at any of these stages results in MCD.

Periventricular heterotopia

Periventricular heterotopia (PH) refers to nodules of neurons found along the ventricular wall of the lateral ventricles, with an apparently normal cerebral cortex. This condition most likely represents a disorder of the initiation of migration in a small subpopulation of neurons while the majority of neurons successfully migrate out to the cerebral cortex. Pathologically, the nodules consist of normal appearing neurons and glial cells, with myelinated fibers and gliosis26.

Affected patients often develop various types of seizures as the presenting symptom. While some patients manifest with seizures during the first few years of life, the majority of patients present in adolescence. Approximately 90% of patients with PH have epilepsy27, which may be easily controlled or refractory. There is no clear relationship between the epilepsy severity and extent of nodular heterotopia. In general, these patients have normal intelligence. However some patients may have learning problems such as impaired reading fluency that is out of proportion to their intelligence28.

Brain imaging using MRI demonstrates the typical nodules along the ventricular walls (Figure 1C). The pattern of involvement can be used to help to distinguish those with X-linked dominant versus those with autosomal recessive mutations. Patients with X-linked dominant mutations typically have bilateral, nearly contiguous periventricular nodular heterotopia with thinning of the corpus callosum and posterior fossa abnormalities, such as cerebellar hypoplasia, and enlarged cisterna magna29. On the other hand, patients with autosomal recessive mutations have microcephaly, slightly enlarged ventricles, and delayed myelination30. Symmetrical nodular heterotopia lining the ventricles are again seen and the overlying cortex may be thinned with abnormal gyri11.

PH can be caused by genetic mutations or it can be acquired due to extrinsic factors, such as infection, injury, or radiation31,32,33. So far, X-linked dominant mutations in FLNA (Filamin A) and autosomal recessive mutations in ARFGEF2 (ADP-ribosylation factor guanine exchange factor 2) are associated with PH (Table 1). FLNA is an actin-binding phosphoprotein that stabilizes the cytoskeleton and mediates focal adhesions along the ventricular epithelium34. ARFGEF2 encodes for the BIG2 protein which converts guanine diphosphate (GDP) to guanine triphosphate (GTP) and thereby activates the ADP-ribosylation factors (ARFs). ARFs regulate vesicle trafficking and the transport of molecules from the interior of the cell to its surface, where they may attach and interact with other substances, or be secreted by the cell. In this respect, ARFGEF2 may assist in the transport of FLNA to the cell surface. FLNA may subsequently be required for the initial attachment of neurons onto the radial glial scaffolding prior to migration from the ventricular zone35. Failure of migratory neurons to attach onto the radial glia could lead to heterotopia formation. Alternatively, both proteins are highly expressed along the neuroepithelial lining, and likely influence cell adhesion. Loss of neuroependymal integrity, similar to that seen with cobblestone lissencephaly, could lead to nodule formation along the lateral ventricles35.

Additional insight into the pathogenic mechanisms underlying this cortical malformation has been gained from mice that develop periventricular heterotopia. Sarkisian and colleagues recently reported that loss of MEKK4, a MAP kinase that regulates the Stress-activated Protein Kinase Activator SEK-1, results in heterotopia formation in mice36. Interestingly, phosphorylation of FLNA at Ser2152 depends on MEKK4/SEK1 signaling and phosphorylation at this site regulates FLNA localization at the cell membrane. Other studies have shown that the hyh (hydrocephalus with hop gait) mouse phenotype is due to a mutation in the Napa gene, which encodes for the vesicle trafficking protein αSnap37. Loss of αSnap function leads to denudation of the neuroepithelium and heterotopia formation38 (personal observations). The αSnap protein is involved in SNAP receptor (SNARE)-mediated vesicle fusion and thus, similar to ARFGEF2 mutations in humans, suggesting that it plays a role in vesicle trafficking in PH formation. Finally, recent studies have suggested that the actin regulating RhoGTPase Cdc42 can disrupt the neuroependymal lining, vesicle trafficking of polarized protein, and lead to heterotopic neurons along the ventricle39,40. As actin is required for some forms of vesicle trafficking, it is possible that disruption of genes which are directly or indirectly linked to vesicle transport may be responsible for PH formation.

Subcortical band heterotopia

Subcortical band heterotopia, also known as “double cortex” syndrome, refers to a band of subcortical heterotopia neurons, located midway between the ventricles and the cerebral cortex41. The disorder is seen primarily in females and typically causes varying degrees of mental retardation and almost all of them have epilepsy. Approximately two thirds of patients with epilepsy ultimately develop intractable seizures42.

MRI of the brain in subcortical band heterotopia demonstrates two parallel layers of gray matter: a thin outer ribbon and a thick inner band, separated by a very thin layer of white matter between them (Figure 1D). The severity of epilepsy and developmental delay is directly correlated with the degree of migration arrest, as indicated by the thickness of the subcortical band heterotopia43.

Subcortical band heterotopia is caused by mutations in the microtubule-associated DCX gene. The DCX protein is thought to direct neuronal migration by regulating the organization and stability of microtubules, necessary for neuronal motility. The malformation is seen only in females, as the gene is found on the X-chromosome. Since there are two X chromosomes in females, after X-inactivation, only some neurons lose doublecortin function. These neurons with the mutant DCX gene fail to migrate into the cortex and thus form the underlying heterotopic band, while neurons which express the normal gene successfully migrate out to the cortical plate. Males with DCX mutations develop classical lissencephaly.

Classical (Type I) Lisssencephaly

Lissencephaly refers to “smooth brain” in which there is loss of the normal gyri and sulci of the brain. The severity of the malformation may range from agyria and pachygyria, to subcortical band heterotopia with a relatively normal gyral pattern. The cortex lacks the normal lamination and consists of only 4 layers instead of the typical 6 layers. Patients usually have severe mental retardation, epilepsy, and often also have microcephaly.

Several genes have been identified giving rise to classical lissencephaly: LIS1 (Lissencephaly1, autosomal dominant)44, DCX (Doublecortin, X-linked dominant)45, TUBA1A (Tubulin alpha 1A, autosomal dominant)46,47, ARX (Aristaless, X-linked dominant) 48. and RELN (Reelin, autosomal recessive)48 (Table 1). Some characteristic differences in the clinical and radiographic presentation of these different lissencephaly disorders help to differentiate the causative genes.

Mutations in the LIS1, DCX, and TUBA1A generally cause similar clinical phenotypes, including microcephaly, mental retardation, with or without epilepsy, and motor deficits. The severity of isolated lissencephaly may be related to the type and location of the mutation49. Complete deletions of the LIS1 and contiguous genes on chromosome 17p13.3 cause Miller-Dieker Syndrome (MDS). MDS is characterized by lissencephaly with additional distinct facial features, including prominent forehead, bitemporal hollowing, short nose with upturned nares, protuberant upper lip, and small jaw50,51. Mutations in ARX cause the X-linked lissencephaly syndrome with ambiguous genitalia (XLAG)52. These patients have neonatal-onset epilepsy, hypothalamic dysfunction causing temperature dysregulation, chronic diarrhea, and ambiguous genitalia (micropenis and cryptorchidism)53. Mutations in RELN give rise to seizures, developmental delay and hypotonia. Moreover, the loss of cerebellar organization likely contributes to ataxia.

MRI of the brain in classical lissencephaly demonstrates an hour-glass configuration with areas of pachygyria and agyria and a shallow Sylvian fissure (Figure 1E). Differences in the location of involvement may be used to differentiate between LIS1 and DCX mutations11,54. The parietal and occipital regions are more severely affected in patients with LIS1 mutations, whereas the frontal and temporal regions are more severely affected in patients with DCX mutations. MRI of the brain in patients with TUBA1A mutations demonstrate pachygyria or agyria, cerebellar hypoplasia with particular involvement of the inferior vermis, brainstem hypolasia, partial or complete agenesis of the corpus callosum, and ventricular dilatation46,47. Additionally, the posterior gyral malformations were more severe than the anterior regions, creating a posterior-anterior gradient. In individuals harboring ARX mutations, the lissencephaly is again worse posteriorly than anteriorly (posterior agyria and anterior pachygyria) and there is absence of the corpus callosum by MRI. The cortex is moderately thickened (5-10mm) with white matter signal abnormalities as well as a cystic or fragmented basal ganglia52,48. Finally in RELN mutations, the lissencephaly is associated with cerebellar hypoplasia and hippocampal and brainstem abnormalities.

Both LIS1 and DCX proteins appear to be regulators of microtubules, which are a part of the cytoskeleton of a cell, regulating cellular shape and motility. The DCX protein interacts with microtubules and contributes to their stability41,55,56. The LIS1 protein also likely interacts with microtubule-binding proteins and regulates neuronal migration by binding microtubules and assisting with the forward translocation of the cell soma toward the leading edge of the migrating cell57,58. Neurons which are heterozygous for the LIS1 mutation have reduced cell motility57. Disruption of microtubule function through LIS1 mutations also interferes with spindle orientation and mitosis18,59. This interruption in cell proliferation may contribute to the microcephaly seen in this disorder, as well as the ectopic localization of a heterogeneous population of differentiated neurons within the deep layers of the lissencephalic cortex59.

The TUBA1A gene encodes for brain-specific alpha tubulin. Alpha and beta tubulins are the main component of microtubules required for cell movement. Human mutations in TUBA1A are thought to affect the folding of tubulin heterodimers and also influence interactions with proteins that bind microtubules (doublecortin and kinesin KIF1A)60. Given that microtubules play an important role in neuronal migration, it would be reasonable to postulate that disruption of microtubular function could lead to deficits in the motility of neuronal progenitor cells and lissencephaly46,47.

ARX is a homeobox gene which is expressed in the ganglionic eminences and the neocortical ventricular zone61. In mice with ARX mutations, there is an accumulation of immature neurons in lateral and medial ganglionic eminences and both radial and tangential migration toward the cortex and striatum are significantly reduced61. Impaired differentiation of cortical GABAergic interneurons is also observed in those neurons harboring the mutation. In addition to lissencephaly, mutations in the ARX gene cause a variety of other neurologic conditions including X-linked West syndrome62, X-linked mental retardation63, myoclonic epilepsy62, and Partington disease (dystonia, epilepsy and mental retardation)64. As homeobox genes initiate a cascade of cellular events, it is difficult to ascertain which particular pathways cause the underlying lissencephaly. However, the ARX gene clearly plays an important role in proliferation of neural precursors and differentiation of the forebrain.

Appropriate cell migration relies on proper intracellular and extracellular molecular signals. LIS1, DCX, and TUBA1A mutations seem to affect the intrinsic motility of neural progenitor cells. Extrinsic signals and cellular interactions also play an important role in guiding appropriate cellular migration. Reelin is a signaling glycoprotein secreted by the early neurons on the surface of the cerebral cortex known as the Cajal Retzius cells. Activation of the Reelin signaling pathway is thought to be essential for proper positioning of migratory neurons into the appropriate lamina of the cortex65. In mice, loss of reelin causes disorganized lamination of the cerebral cortex66, whereby the layers are inverted, with earlier born cells forming the superficial layers of cortex and later born neurons forming the deeper layers.

While disruption in microtubule and microtubule associated proteins such as doublecortin, lissencephaly1 and alpha-tubulin would understandably alter neuronal motility and migration, the potential role of reelin in giving rise to lissencephaly is not entirely clear. However, phenotypic similarities between the reeler mouse mutant and genetically modified mice null for cyclin dependent kinase 5 (cdk5)67 or cdk5 activator p35 (p35 inverted layering)68 do suggest a shared pathway. Mice lacking p35, cdk5, or reelin all show disrupted lamination and inverted lamination. The Lis-1 interacting protein Ndel1 has been shown to be a cdk5 substrate, and to be involved in neuronal motility. Cdk5 is also a substrate for the microtubule associated protein tau69. Thus, cdk5 might connect Reelin signaling with other lissencephaly protein complexes such as the Ndel1–Lis1 complex to control microtubule dynamics and neuronal migration.

Inhibitory interneurons, or GABAergic neurons, constitute approximately 20-30% of all cortical neurons. As mentioned earlier, they originate from the medial, lateral and caudal ganglionic eminences, migrate tangentially at first, and then radially before distribution within the different layers of the cerebral cortex. These interneurons are classified into subtypes and animal studies have shown that the Lhx6 gene is preferentially expressed in some tangentially migrating GABAergic interneurons. The Lhx6 gene encodes for one of the homeodomain transcription factors that regulate neuronal subtype specifications and cell fate decisions70. More recently, Liodis and colleagues demonstrated that Lhx6 plays an important role in the normal tangential and radial migration of these interneurons during embryogensesis71.

Disorders due to abnormal neuronal migration arrest

Cobblestone (Type II) lissencephaly

Cobblestone lissencephaly, also known as type II lissencephaly, refers to the nodular appearance of the cerebral cortex caused by disorganization of the cortical layers, and over-migration of neurons through the pial surface of the brain into the leptomeninges. It is associated with various eye abnormalities and congenital muscular dystrophies.

Based on severity, cobblestone lissencephaly has been divided into three different classes. The mild form is seen in Fukuyama congenital muscular dystrophy (FCMD) that affects primarily the Japanese population72. Patients typically present with hypotonia and generalized weakness in infancy. The majority of patients are unable to walk unsupported73. Mental retardation is a universal finding and some patients also have epilepsy. The moderate form is seen in muscle-eye-brain disease (MEB) that primarily affects the Finnish population74. Early onset of severe myopia, glaucoma, optic disc pallor and retinal hypoplasia are the typical eye findings. Patients also have mental retardation, myoclonic jerks, and congenital muscular dystrophy. Finally, the more severe form of cobblestone lissencephaly is seen in Walker-Warburg Syndrome (WWS) which typically results in death within a few months after birth75. Ophthalmologic abnormalities include retinal dysplasia, microphthalmia, cataracts, and glaucoma. Again, congenital muscular dystrophy is a key feature.

Brain imaging using MRI demonstrates the typical cobblestone lissencephaly (Figure 1F) as well as a spectrum of CNS abnormalities of varying degrees of severity11. All of the abnormalities are most severe in Walker-Warburg syndrome. A “Z-shaped” hypoplastic brainstem is considered a key feature. Other typical MRI findings include abnormal signal in the white matter due to hypomyelination and polymicrogyria as seen in FCMD, which is particularly associated with frontal polymicrogyria with occipital cobblestone lissencephaly. Aqueductal stenosis with hydrocephalus, vermian hypogenesis, cerebellar agyria-micropolygyria, patchy abnormal white matter signal, and agenesis or hypogenesis of the corpus callosum can also be seen, as in MEB disease in the Finnish population76. WWS is the most severe form and may demonstrate all of the previously mentioned findings, as well as occipital encephalocele11.

Cobblestone lissencephaly follows an autosomal recessive inheritance pattern. Four associated genes have been identified: POMT1 (Protein-O-mannosyltransferase 1) and POMT2 (Protein-O-mannosyltransferase 2) for WWS, POMGnT1 (Protein O-mannose 1,2-N-acetylglucosaminyltransferase) linked to chromosome 1p32-34 for the Finnish MEB disorder77,78, and Fukutin on chromosome 9q31for FCMD79 (Table 1). All of these genes are involved in the glycosylation of alpha dystroglycan, which are highly glycosylated proteins and act as receptors for the multiple extracellular matrix molecules that maintain stability of the cell surface. Mutations in these genes affect the O-glycosylation of alpha dystroglycan, thereby compromising the integrity of the dystrophy-associated extracellular matrix adhesion complex and lead to weakening of the structural integrity of the superficial marginal zone or the cortex. Migratory neurons are then able to “over-migrate” beyond this structural barrier onto the pial surface, forming the typical cobblestone, or bumpy surface.

Disruption in the basal lamina along the surface of the brain in mice similarly leads to a cobblestone phenotype in mice. Presenilin1 (PS1) is a transmembrane protein, located in the Golgi apparatus, and best known for its processing of amyloid precursor protein. Presenilin1-deficient mice develop a cortical dysplasia resembling human cobblestone lissencephaly, with leptomeningeal fibrosis and migration of cortical-plate neurons beyond their normal position into the marginal zone and subarachnoid space. PS1 deficiency interferes with the ability of the leptomeningeal cells to support the Cajal-Retzius cells and maintain an intact pial basement membrane, resulting in both over migration of neurons and premature termination of neuronal migration of both radially migrating neurons and Cajal-Retzius neurons. Pathologic examinations reveal a loss of the Cajal-Retzius neurons within the marginal zone, depletion of the extracellular matrix protein reelin and chondroitin sulfate proteoglycans80. Another animal model to demonstrate the importance of the surface basement membrane utilizes isolated deletions of various basement membrane constituents or receptors, such as alpha 6 integrin, resulting in abnormal laminar organization of the brain and retina, with ectopic neuronal growth on the brain surface, similar to WWS81. Loss of integrin linked kinase in mice results in a similar lissencephalic phenotype82. Integrin linked kinase is a scaffold and kinase that links integrin receptors to the actin cytoskeleton and to signaling pathways involved in extracellular matrix deposition. Overall, disruption of mouse or human genes involved in basal lamina formation appear to be responsible for the development cobblestone lissencephaly.

Disorders due to abnormal neuronal organization

Cortical organization involves a process of synaptogenesis and neuronal maturation which are further refined via synapse pruning and apoptosis.

Polymicrogyria and Schizencephaly

Polymicrogyria refers to an excessive number of small gyri separated by shallow sulci, giving the surface of the cortex its characteristic lumpy appearance. Polymicrogyria can be focal or diffuse, unilateral or bilateral. Unilateral involvement may be associated with variable cognitive impairment, congenital hemiparesis, focal seizures83, and visual field defects84. Deletion of 22q11.2 has been found to be associated with polymicrogyria and seems to have a predisposition for the right hemisphere85.

Bilateral involvement of the cortex is frequently seen, with a symmetric or asymmetric distribution, affecting the frontal, fronto-parietal, parieto-occipital, perisylvian, and mesial occipital regions. There is a wide spectrum of clinical manifestations owing to the various locations that are involved. For example, bilateral frontoparietal polymicrogyria is associated with developmental delay, hypertonicity, ataxia, and refractory seizures86. Congenital bilateral perisylvian syndrome (CBPS) is one of the best described syndromes. Affected patients have pseudobulbar palsy, spastic quadriparesis, and epilepsy. Between 50-85% of patients develop seizures, ranging from atypical absence, tonic, atonic, and generalized tonic-clonic seizures87. Imaging of the brain using MRI demonstrates small irregular gyri and an indistinct gray and white matter junction11. The thickness of the cortex may be normal or abnormally thick or thin.

Familial patterns have been recognized in bilateral frontoparietal, bilateral perisylvian, and generalized polymicrogyria. Bilateral frontal and parietal polymicrogyria seem to be associated with mutations in the G-protein-coupled receptor gene (GPR56)88,89. Expression of this gene appears to be highest in the neuronal progenitor cells along the ventricular and subventricular zones. The assumption is that this gene plays a role in regional organization of the brain.

Schizencephaly is classified within the same group as polymicrogyria. Schizencephaly refers to a cleft extending from the cerebral cortex to the ventricle and is typically lined by polymicrogyric cortex. It is in fact considered to be an extreme form of polymicrogyria90. Schizencephaly can be unilateral or bilateral and tends involve the insular, precentral and postcentral regions11. Type I schizencephaly refers to “closed-lip” clefts or small defects that are fused. In contrast, type II schizencephaly refers to “open-lip” clefts or large defects which are filled with fluid. The neurologic manifestations of the disorder depend on the anatomic location and type of the abnormality. Patients with type I lesions tend to be mildly affected and have partial seizures or spastic hemiparesis. On the other hand, patients with type II defects (open cleft) tend to have severe developmental delay, microcephaly, seizures, and spasticity. In particular, those with bilateral involvement have spastic quadriparesis and severe cognitive impairment. Non CNS manifestations have also been reported, such as gastroschisis, and bowel atresias91. Radiographically, in addition to the schizencephaly seen on MRI, an absent or deficient septum pellucidum may be seen and is often associated with temporal or occipital clefts11. The gray matter lining the cleft is nodular, with a polymicrogyric appearance.

Familial cases have been identified and have helped to shed light on the genetic basis of the disorder92. The inheritance pattern is still unclear although the mutations are thought to be autosomal dominant93. Initial reports suggest that EMX2 gene mutations may be associated with type II schizencephaly92; however, this finding needs to be confirmed in additional studies.

Management

As discussed above, the phenotype of MCD is extremely heterogeneous and the severity of the neurologic deficits can be quite varied, ranging from relatively mild to severe. Not surprisingly, given the abnormalities in the cerebral cortex, patients frequently suffer from epilepsy which may be refractory to pharmacologic treatment. Those patients who fail 3 antiepileptic medications are less likely to have their seizures controlled with additional trials of medications and epilepsy surgery should be considered. In addition to better seizure control, the goals of the surgery may include improvement of cognitive and psychosocial function, and ultimately better quality of life. The goals obviously need to be balanced against the risk of potential functional deficits that might result from the surgery. A detailed step-wise presurgical evaluation must be undertaken to evaluate whether the patient is an appropriate surgical candidate.

Vagus nerve stimulation (VNS) was approved in 1997 as adjunct treatment of refractory epilepsy for patients age 12 and older94. The device is implanted surgically and delivers stimulation to the vagus nerve at various frequencies, but the exact mechanism is unknown. Up to 43% of patients may experience a greater than 50% reduction of seizure frequency at the end of 2 years95. Thus, VNS is an option for patients who may not be good surgical candidates or who have failed surgery.

Aside from seizure control, management of these patients requires a multidisciplinary team approach to address both the medical and the psychosocial aspects of the disorder. As the genetic basis for many of these disorders have been identified, genetic testing may be possible for the patient as well as the family members. Appropriate genetic counseling may be an important aspect of management particularly for parents are planning to have more children.

Conclusion

With recent advances in neuroimaging, there is a significant increase in the recognition of MCD as a cause of epilepsy and neurologic dysfunction. Research in delineating the genetic and molecular basis of these disorders has given us greater insight into the pathogenesis of not only the malformations, but also the processes involved in normal cortical development. From a clinical perspective, improved diagnosis of MCD will allow for better treatment of symptomatic epilepsy (including offering surgical options when appropriate). The possibility of genetic testing and genetic counseling for families also play an important role in the overall management of patients with MCD. Hopefully, further research in elucidating the genetic and pathophysiologic mechanisms of MCD will lead the development of potential treatment strategies at various stages of development.

Acknowledgments

Sponsorship: VLS is a Beckman Young Investigator and a recipient of the Doris Duke Clinical Scientist Development Award.

Contributor Information

Trudy Pang, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Ramin Atefy, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Volney Sheen, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

References

  • 1.Kuzniecky RI. Magnetic resonance imaging in developmental disorders of the cerebral cortex. Epilepsia. 1994;35(Suppl 6):S44–56. doi: 10.1111/j.1528-1157.1994.tb05988.x. [DOI] [PubMed] [Google Scholar]
  • 2.Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. A developmental and genetic classification for malformations of cortical development. Neurology. 2005;65:1873–1887. doi: 10.1212/01.wnl.0000183747.05269.2d. [DOI] [PubMed] [Google Scholar]
  • 3.Lombroso CT. Can early postnatal closed head injury induce cortical dysplasia. Epilepsia. 2000;41:245–253. doi: 10.1111/j.1528-1157.2000.tb00148.x. [DOI] [PubMed] [Google Scholar]
  • 4.Sarnat HB. Disturbances of late neuronal migrations in the perinatal period. American journal of diseases of children (1960) 1987;141:969–980. doi: 10.1001/archpedi.1987.04460090046022. [DOI] [PubMed] [Google Scholar]
  • 5.Chenn A, McConnell SK. Cleavage orientation and the asymmetric inheritance of Notch1 immunoreactivity in mammalian neurogenesis. Cell. 1995;82:631–641. doi: 10.1016/0092-8674(95)90035-7. [DOI] [PubMed] [Google Scholar]
  • 6.Anderson SA, Eisenstat DD, Shi L, Rubenstein JL. Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science. 1997;278:474–476. doi: 10.1126/science.278.5337.474. [DOI] [PubMed] [Google Scholar]
  • 7.Anderson S, Mione M, Yun K, Rubenstein JL. Differential origins of neocortical projection and local circuit neurons: role of Dlx genes in neocortical interneuronogenesis. Cereb Cortex. 1999;9:646–654. doi: 10.1093/cercor/9.6.646. [DOI] [PubMed] [Google Scholar]
  • 8.Kriegstein AR, Noctor SC. Patterns of neuronal migration in the embryonic cortex. Trends in neurosciences. 2004;27:392–399. doi: 10.1016/j.tins.2004.05.001. [DOI] [PubMed] [Google Scholar]
  • 9.Metin C, Baudoin JP, Rakic S, Parnavelas JG. Cell and molecular mechanisms involved in the migration of cortical interneurons. The European journal of neuroscience. 2006;23:894–900. doi: 10.1111/j.1460-9568.2006.04630.x. [DOI] [PubMed] [Google Scholar]
  • 10.Sidman RL, Rakic P. Neuronal migration, with special reference to developing human brain: a review. Brain Res. 1973;62:1–35. doi: 10.1016/0006-8993(73)90617-3. [DOI] [PubMed] [Google Scholar]
  • 11.Osborn AG. Brain. 1. Vol. 1. Salt Lake City, Utah: Amirsys; 2004. Diagnostic imaging. various pagings. [Google Scholar]
  • 12.Zhong X, Pfeifer GP, Xu X. Microcephalin encodes a centrosomal protein. Cell cycle (Georgetown, Tex. 2006;5:457–458. doi: 10.4161/cc.5.4.2481. [DOI] [PubMed] [Google Scholar]
  • 13.Trimborn M, Bell SM, Felix C, et al. Mutations in microcephalin cause aberrant regulation of chromosome condensation. American journal of human genetics. 2004;75:261–266. doi: 10.1086/422855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhong X, Liu L, Zhao A, Pfeifer GP, Xu X. The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein. Cell cycle (Georgetown, Tex. 2005;4:1227–1229. doi: 10.4161/cc.4.9.2029. [DOI] [PubMed] [Google Scholar]
  • 15.do Carmo Avides M, Glover DM. Abnormal spindle protein, Asp, and the integrity of mitotic centrosomal microtubule organizing centers. Science. 1999;283:1733–1735. doi: 10.1126/science.283.5408.1733. [DOI] [PubMed] [Google Scholar]
  • 16.Bond J, Roberts E, Springell K, et al. A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nature genetics. 2005;37:353–355. doi: 10.1038/ng1539. [DOI] [PubMed] [Google Scholar]
  • 17.Hung LY, Tang CJ, Tang TK. Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP) which is associated with the gamma-tubulin complex. Molecular and cellular biology. 2000;20:7813–7825. doi: 10.1128/mcb.20.20.7813-7825.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Feng Y, Walsh CA. Mitotic spindle regulation by Nde1 controls cerebral cortical size. Neuron. 2004;44:279–293. doi: 10.1016/j.neuron.2004.09.023. [DOI] [PubMed] [Google Scholar]
  • 19.Tinkle BT, Schorry EK, Franz DN, Crone KR, Saal HM. Epidemiology of hemimegalencephaly: a case series and review. Am J Med Genet A. 2005;139:204–211. doi: 10.1002/ajmg.a.31024. [DOI] [PubMed] [Google Scholar]
  • 20.Sisodiya SM. Malformations of cortical development: burdens and insights from important causes of human epilepsy. Lancet Neurol. 2004;3:29–38. doi: 10.1016/s1474-4422(03)00620-3. [DOI] [PubMed] [Google Scholar]
  • 21.Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry. 1971;34:369–387. doi: 10.1136/jnnp.34.4.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fauser S, Huppertz HJ, Bast T, et al. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain. 2006;129:1907–1916. doi: 10.1093/brain/awl133. [DOI] [PubMed] [Google Scholar]
  • 23.Kuzniecky R, Murro A, King D, et al. Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology. 1993;43:681–687. doi: 10.1212/wnl.43.4.681. [DOI] [PubMed] [Google Scholar]
  • 24.Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 2002;125:1719–1732. doi: 10.1093/brain/awf175. [DOI] [PubMed] [Google Scholar]
  • 25.Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51:1256–1262. doi: 10.1212/wnl.51.5.1256. [DOI] [PubMed] [Google Scholar]
  • 26.Tassi L, Colombo N, Cossu M, et al. Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain. 2005;128:321–337. doi: 10.1093/brain/awh357. [DOI] [PubMed] [Google Scholar]
  • 27.Dubeau F, Tampieri D, Lee N, et al. Periventricular and subcortical nodular heterotopia. A study of 33 patients. Brain. 1995;118(Pt 5):1273–1287. doi: 10.1093/brain/118.5.1273. [DOI] [PubMed] [Google Scholar]
  • 28.Chang BS, Ly J, Appignani B, et al. Reading impairment in the neuronal migration disorder of periventricular nodular heterotopia. Neurology. 2005;64:799–803. doi: 10.1212/01.WNL.0000152874.57180.AF. [DOI] [PubMed] [Google Scholar]
  • 29.Fox JW, Lamperti ED, Eksioglu YZ, et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron. 1998;21:1315–1325. doi: 10.1016/s0896-6273(00)80651-0. [DOI] [PubMed] [Google Scholar]
  • 30.Sheen VL, Ganesh VS, Topcu M, et al. Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nature genetics. 2004;36:69–76. doi: 10.1038/ng1276. [DOI] [PubMed] [Google Scholar]
  • 31.Ferrer I, Santamaria J, Alcantara S, Zujar MJ, Cinos C. Neuronal ectopic masses induced by prenatal irradiation in the rat. Virchows Archiv. 1993;422:1–6. doi: 10.1007/BF01605126. [DOI] [PubMed] [Google Scholar]
  • 32.Wetzburger CL, Van Regemorter N, Szliwowski HB, Abramowicz MJ, Van Bogaert P. Gray matter heterotopia and acute necrotizing encephalopathy in trichothiodystrophy. Pediatr Neurol. 1998;19:392–394. doi: 10.1016/s0887-8994(98)00085-x. [DOI] [PubMed] [Google Scholar]
  • 33.Montenegro MA, Guerreiro MM, Lopes-Cendes I, Guerreiro CA, Cendes F. Interrelationship of genetics and prenatal injury in the genesis of malformations of cortical development. Arch Neurol. 2002;59:1147–1153. doi: 10.1001/archneur.59.7.1147. [DOI] [PubMed] [Google Scholar]
  • 34.Lu J, Tiao G, Folkerth R, Hecht J, Walsh C, Sheen V. Overlapping expression of ARFGEF2 and Filamin A in the neuroependymal lining of the lateral ventricles: insights into the cause of periventricular heterotopia. The Journal of comparative neurology. 2006;494:476–484. doi: 10.1002/cne.20806. [DOI] [PubMed] [Google Scholar]
  • 35.Lu J, Sheen V. Periventricular heterotopia. Epilepsy Behav. 2005;7:143–149. doi: 10.1016/j.yebeh.2005.05.001. [DOI] [PubMed] [Google Scholar]
  • 36.Sarkisian MR, Bartley CM, Chi H, et al. MEKK4 signaling regulates filamin expression and neuronal migration. Neuron. 2006;52:789–801. doi: 10.1016/j.neuron.2006.10.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chae TH, Kim S, Marz KE, Hanson PI, Walsh CA. The hyh mutation uncovers roles for alpha Snap in apical protein localization and control of neural cell fate. Nature genetics. 2004;36:264–270. doi: 10.1038/ng1302. [DOI] [PubMed] [Google Scholar]
  • 38.Jimenez AJ, Tome M, Paez P, et al. A programmed ependymal denudation precedes congenital hydrocephalus in the hyh mutant mouse. Journal of neuropathology and experimental neurology. 2001;60:1105–1119. doi: 10.1093/jnen/60.11.1105. [DOI] [PubMed] [Google Scholar]
  • 39.Cappello S, Attardo A, Wu X, et al. The Rho-GTPase cdc42 regulates neural progenitor fate at the apical surface. Nature neuroscience. 2006;9:1099–1107. doi: 10.1038/nn1744. [DOI] [PubMed] [Google Scholar]
  • 40.Chen L, Liao G, Yang L, et al. Cdc42 deficiency causes Sonic hedgehog-independent holoprosencephaly. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:16520–16525. doi: 10.1073/pnas.0603533103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 1999;23:257–271. doi: 10.1016/s0896-6273(00)80778-3. [DOI] [PubMed] [Google Scholar]
  • 42.Guerrini R, Carrozzo R. Epilepsy and genetic malformations of the cerebral cortex. American journal of medical genetics. 2001;106:160–173. doi: 10.1002/ajmg.1569. [DOI] [PubMed] [Google Scholar]
  • 43.Barkovich AJ, Guerrini R, Battaglia G, et al. Band heterotopia: correlation of outcome with magnetic resonance imaging parameters. Ann Neurol. 1994;36:609–617. doi: 10.1002/ana.410360409. [DOI] [PubMed] [Google Scholar]
  • 44.Reiner O, Carrozzo R, Shen Y, et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 1993;364:717–721. doi: 10.1038/364717a0. [DOI] [PubMed] [Google Scholar]
  • 45.Gleeson JG, Allen KM, Fox JW, et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell. 1998;92:63–72. doi: 10.1016/s0092-8674(00)80899-5. [DOI] [PubMed] [Google Scholar]
  • 46.Poirier K, Keays DA, Francis F, et al. Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A) Human mutation. 2007;28:1055–1064. doi: 10.1002/humu.20572. [DOI] [PubMed] [Google Scholar]
  • 47.Keays DA, Tian G, Poirier K, et al. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell. 2007;128:45–57. doi: 10.1016/j.cell.2006.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bonneau D, Toutain A, Laquerriere A, et al. X-linked lissencephaly with absent corpus callosum and ambiguous genitalia (XLAG): clinical, magnetic resonance imaging, and neuropathological findings. Ann Neurol. 2002;51:340–349. doi: 10.1002/ana.10119. [DOI] [PubMed] [Google Scholar]
  • 49.Cardoso C, Leventer RJ, Matsumoto N, et al. The location and type of mutation predict malformation severity in isolated lissencephaly caused by abnormalities within the LIS1 gene. Human molecular genetics. 2000;9:3019–3028. doi: 10.1093/hmg/9.20.3019. [DOI] [PubMed] [Google Scholar]
  • 50.Dobyns WB, Reiner O, Carrozzo R, Ledbetter DH. Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. Jama. 1993;270:2838–2842. doi: 10.1001/jama.270.23.2838. [DOI] [PubMed] [Google Scholar]
  • 51.Dobyns WB, Curry CJ, Hoyme HE, Turlington L, Ledbetter DH. Clinical and molecular diagnosis of Miller-Dieker syndrome. American journal of human genetics. 1991;48:584–594. [PMC free article] [PubMed] [Google Scholar]
  • 52.Dobyns WB, Berry-Kravis E, Havernick NJ, Holden KR, Viskochil D. X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. American journal of medical genetics. 1999;86:331–337. [PubMed] [Google Scholar]
  • 53.Kitamura K, Yanazawa M, Sugiyama N, et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nature genetics. 2002;32:359–369. doi: 10.1038/ng1009. [DOI] [PubMed] [Google Scholar]
  • 54.Dobyns WB, Truwit CL, Ross ME, et al. Differences in the gyral pattern distinguish chromosome 17-linked and X-linked lissencephaly. Neurology. 1999;53:270–277. doi: 10.1212/wnl.53.2.270. [DOI] [PubMed] [Google Scholar]
  • 55.Francis F, Koulakoff A, Boucher D, et al. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron. 1999;23:247–256. doi: 10.1016/s0896-6273(00)80777-1. [DOI] [PubMed] [Google Scholar]
  • 56.Horesh D, Sapir T, Francis F, et al. Doublecortin, a stabilizer of microtubules. Human molecular genetics. 1999;8:1599–1610. doi: 10.1093/hmg/8.9.1599. [DOI] [PubMed] [Google Scholar]
  • 57.Faulkner NE, Dujardin DL, Tai CY, et al. A role for the lissencephaly gene LIS1 in mitosis and cytoplasmic dynein function. Nature cell biology. 2000;2:784–791. doi: 10.1038/35041020. [DOI] [PubMed] [Google Scholar]
  • 58.Niethammer M, Smith DS, Ayala R, et al. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron. 2000;28:697–711. doi: 10.1016/s0896-6273(00)00147-1. [DOI] [PubMed] [Google Scholar]
  • 59.Sheen VL, Ferland RJ, Harney M, et al. Impaired proliferation and migration in human Miller-Dieker neural precursors. Ann Neurol. 2006;60:137–144. doi: 10.1002/ana.20843. [DOI] [PubMed] [Google Scholar]
  • 60.Moores CA, Perderiset M, Francis F, Chelly J, Houdusse A, Milligan RA. Mechanism of microtubule stabilization by doublecortin. Molecular cell. 2004;14:833–839. doi: 10.1016/j.molcel.2004.06.009. [DOI] [PubMed] [Google Scholar]
  • 61.Colombo E, Collombat P, Colasante G, et al. Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation. J Neurosci. 2007;27:4786–4798. doi: 10.1523/JNEUROSCI.0417-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Stromme P, Mangelsdorf ME, Shaw MA, et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nature genetics. 2002;30:441–445. doi: 10.1038/ng862. [DOI] [PubMed] [Google Scholar]
  • 63.Bienvenu T, Poirier K, Friocourt G, et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Human molecular genetics. 2002;11:981–991. doi: 10.1093/hmg/11.8.981. [DOI] [PubMed] [Google Scholar]
  • 64.Frints SG, Borghgraef M, Froyen G, Marynen P, Fryns JP. Clinical study and haplotype analysis in two brothers with Partington syndrome. American journal of medical genetics. 2002;112:361–368. doi: 10.1002/ajmg.10630. [DOI] [PubMed] [Google Scholar]
  • 65.Dulabon L, Olson EC, Taglienti MG, et al. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron. 2000;27:33–44. doi: 10.1016/s0896-6273(00)00007-6. [DOI] [PubMed] [Google Scholar]
  • 66.Caviness VS., Jr Neocortical histogenesis in normal and reeler mice: a developmental study based upon [3H]thymidine autoradiography. Brain Res. 1982;256:293–302. doi: 10.1016/0165-3806(82)90141-9. [DOI] [PubMed] [Google Scholar]
  • 67.Ohshima T, Ward JM, Huh CG, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:11173–11178. doi: 10.1073/pnas.93.20.11173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron. 1997;18:29–42. doi: 10.1016/s0896-6273(01)80044-1. [DOI] [PubMed] [Google Scholar]
  • 69.Olson EC, Walsh CA. Smooth, rough and upside-down neocortical development. Current opinion in genetics & development. 2002;12:320–327. doi: 10.1016/s0959-437x(02)00305-2. [DOI] [PubMed] [Google Scholar]
  • 70.Grigoriou M, Tucker AS, Sharpe PT, Pachnis V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development. Development (Cambridge, England) 1998;125:2063–2074. doi: 10.1242/dev.125.11.2063. [DOI] [PubMed] [Google Scholar]
  • 71.Liodis P, Denaxa M, Grigoriou M, Akufo-Addo C, Yanagawa Y, Pachnis V. Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. J Neurosci. 2007;27:3078–3089. doi: 10.1523/JNEUROSCI.3055-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev. 1981;3:1–29. doi: 10.1016/s0387-7604(81)80002-2. [DOI] [PubMed] [Google Scholar]
  • 73.Yoshioka M, Kuroki S. Clinical spectrum and genetic studies of Fukuyama congenital muscular dystrophy. American journal of medical genetics. 1994;53:245–250. doi: 10.1002/ajmg.1320530309. [DOI] [PubMed] [Google Scholar]
  • 74.Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB) Brain Dev. 1989;11:147–153. doi: 10.1016/s0387-7604(89)80088-9. [DOI] [PubMed] [Google Scholar]
  • 75.Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. American journal of medical genetics. 1989;32:195–210. doi: 10.1002/ajmg.1320320213. [DOI] [PubMed] [Google Scholar]
  • 76.Towfighi J, Sassani JW, Suzuki K, Ladda RL. Cerebro-ocular dysplasia-muscular dystrophy (COD-MD) syndrome. Acta neuropathologica. 1984;65:110–123. doi: 10.1007/BF00690464. [DOI] [PubMed] [Google Scholar]
  • 77.Cormand B, Avela K, Pihko H, et al. Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. American journal of human genetics. 1999;64:126–135. doi: 10.1086/302206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Developmental cell. 2001;1:717–724. doi: 10.1016/s1534-5807(01)00070-3. [DOI] [PubMed] [Google Scholar]
  • 79.Toda T, Ikegawa S, Okui K, et al. Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy: evidence for strong linkage disequilibrium. American journal of human genetics. 1994;55:946–950. [PMC free article] [PubMed] [Google Scholar]
  • 80.Hartmann D, De Strooper B, Saftig P. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr Biol. 1999;9:719–727. doi: 10.1016/s0960-9822(99)80331-5. [DOI] [PubMed] [Google Scholar]
  • 81.Georges-Labouesse E, Mark M, Messaddeq N, Gansmuller A. Essential role of alpha 6 integrins in cortical and retinal lamination. Curr Biol. 1998;8:983–986. doi: 10.1016/s0960-9822(98)70402-6. [DOI] [PubMed] [Google Scholar]
  • 82.Niewmierzycka A, Mills J, St-Arnaud R, Dedhar S, Reichardt LF. Integrin-linked kinase deletion from mouse cortex results in cortical lamination defects resembling cobblestone lissencephaly. J Neurosci. 2005;25:7022–7031. doi: 10.1523/JNEUROSCI.1695-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Caraballo RH, Cersosimo RO, Mazza E, Fejerman N. Focal polymicrogyria in mother and son. Brain Dev. 2000;22:336–339. doi: 10.1016/s0387-7604(00)00125-x. [DOI] [PubMed] [Google Scholar]
  • 84.Chang BS, Apse KA, Caraballo R, et al. A familial syndrome of unilateral polymicrogyria affecting the right hemisphere. Neurology. 2006;66:133–135. doi: 10.1212/01.wnl.0000191393.06679.e9. [DOI] [PubMed] [Google Scholar]
  • 85.Robin NH, Taylor CJ, McDonald-McGinn DM, et al. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A. 2006;140:2416–2425. doi: 10.1002/ajmg.a.31443. [DOI] [PubMed] [Google Scholar]
  • 86.Straussberg R, Gross S, Amir J, Gadoth N. A new autosomal recessive syndrome of pachygyria. Clinical genetics. 1996;50:498–501. doi: 10.1111/j.1399-0004.1996.tb02721.x. [DOI] [PubMed] [Google Scholar]
  • 87.Kuzniecky R, Andermann F, Guerrini R. Congenital bilateral perisylvian syndrome: study of 31 patients. The CBPS Multicenter Collaborative Study. Lancet. 1993;341:608–612. doi: 10.1016/0140-6736(93)90363-l. [DOI] [PubMed] [Google Scholar]
  • 88.Piao X, Basel-Vanagaite L, Straussberg R, et al. An autosomal recessive form of bilateral frontoparietal polymicrogyria maps to chromosome 16q12.2-21. American journal of human genetics. 2002;70:1028–1033. doi: 10.1086/339552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Piao X, Chang BS, Bodell A, et al. Genotype-phenotype analysis of human frontoparietal polymicrogyria syndromes. Ann Neurol. 2005;58:680–687. doi: 10.1002/ana.20616. [DOI] [PubMed] [Google Scholar]
  • 90.Barkovich AJ, Kjos BO. Schizencephaly: correlation of clinical findings with MR characteristics. Ajnr. 1992;13:85–94. [PMC free article] [PubMed] [Google Scholar]
  • 91.Curry CJ, Lammer EJ, Nelson V, Shaw GM. Schizencephaly: heterogeneous etiologies in a population of 4 million California births. Am J Med Genet A. 2005;137:181–189. doi: 10.1002/ajmg.a.30862. [DOI] [PubMed] [Google Scholar]
  • 92.Brunelli S, Faiella A, Capra V, et al. Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nature genetics. 1996;12:94–96. doi: 10.1038/ng0196-94. [DOI] [PubMed] [Google Scholar]
  • 93.Jansen A, Andermann E. Genetics of the polymicrogyria syndromes. Journal of medical genetics. 2005;42:369–378. doi: 10.1136/jmg.2004.023952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Schachter SC, Saper CB. Vagus nerve stimulation. Epilepsia. 1998;39:677–686. doi: 10.1111/j.1528-1157.1998.tb01151.x. [DOI] [PubMed] [Google Scholar]
  • 95.Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1:477–482. doi: 10.1016/s1474-4422(02)00220-x. [DOI] [PubMed] [Google Scholar]

RESOURCES